Equities / Sectors / Healthcare
Healthcare
#6 by market capPharmaceuticals, biotechnology, medical devices and care providers. 564 US-listed equities across 10 industries; the sector accounts for 9.2% of tracked equity market cap and 10.1% of daily volume.
Market cap
$7.717T
+0.74%
$56.429B · 1D
Sector weight
9.2%
of tracked market cap
Volume 24h
$2.229B
10.1% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$153.576B
3.7% net margin
P/E (TTM)
50×
Market 30.5×
Dividend yield
1.8%
Market 1.3%
Employees
4.4M
Across 564 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
384.2
Mega caps
7
Median cap
$1.408B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
P/E (TTM): 50× · market 20×
P/S: 1.8× · market 2.7×
EV / EBITDA: 19.3× · market 13×
Operating margin: 7.9% · market 8.5%
Dividend yield: 1.8% · market 2.3%
Trading at a 63.8% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | +0.74% | +0.77% | -0.04% |
| 1 week | -1.73% | +0.57% | -2.30% |
| 1 month | -3.04% | +1.29% | -4.33% |
| 3 months | +1.33% | +2.63% | -1.29% |
| Year to date | +9.12% | +12.63% | -3.51% |
| 1 year | +17.21% | +14.05% | +3.16% |
Constituents
564 equities
Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.025T | 13.3% | $1.15K | +0.58% | -2.87% | -0.91% | $66.78M | 38.4× |
Johnson & Johnson JNJ · US | Drug Manufacturers - General | $609.595B | 7.9% | $253.13 | -1.13% | -6.67% | -8.02% | $42.1M | 29× |
AbbVie Inc. ABBV · US | Drug Manufacturers - General | $466.241B | 6% | $263.85 | +0.39% | -0.19% | +0.81% | $36.94M | 74.4× |
Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $345.918B | 4.5% | $140.07 | -2.94% | -5.85% | -7.63% | $37.91M | 38.7× |
UnitedHealth Group Inc. UNH · US | Healthcare Plans | $338.746B | 4.4% | $374.31 | +0.65% | -0.61% | -6.34% | $53.87M | 24× |
Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $249.261B | 3.2% | $670.74 | +2.43% | -0.63% | +10.22% | $43.81M | 36.4× |
Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $217.694B | 2.8% | $402.69 | -0.09% | -2.88% | -9.07% | $41.36M | 24.9× |
Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $178.791B | 2.3% | $144.07 | -0.46% | -4.55% | -3.70% | $16.62M | -55.2× |
Abbott Laboratories ABT · US | Medical Devices | $174.974B | 2.3% | $100.46 | +3.03% | -0.82% | -9.06% | $29.02M | 27.9× |
Pfizer Inc. PFE · US | Drug Manufacturers - General | $156.01B | 2% | $27.38 | -1.53% | -4.50% | -5.65% | $38.12M | 20.8× |
Danaher Corp. DHR · US | Diagnostics & Research | $155.06B | 2% | $220.60 | +3.06% | -1.73% | +5.09% | $17.54M | 38.7× |
Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $143.349B | 1.9% | $405.06 | +3.34% | -0.03% | +8.92% | $17.69M | 45.7× |
| Biotechnology | $127.216B | 1.6% | $502.14 | -0.51% | -4.57% | -9.81% | $13.76M | 28.9× | |
Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $119.819B | 1.6% | $58.69 | -4.03% | -6.63% | -13.26% | $46.65M | 12.9× |
Medtronic plc MDT · US | Medical Devices | $112.542B | 1.5% | $87.92 | +1.78% | -0.81% | -4.62% | $141.23M | 21.5× |
CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $111.499B | 1.4% | $87.25 | +0.91% | -2.11% | -10.26% | $50.89M | 22.8× |
McKesson Corporation MCK · US | Medical Distribution | $110.166B | 1.4% | $918.05 | +1.75% | +5.93% | -0.73% | $19.09M | 23.1× |
Stryker Corp. SYK · US | Medical Devices | $108.958B | 1.4% | $284.06 | +3.13% | +4.30% | -9.01% | $30.63M | 29.2× |
HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $94.81B | 1.2% | $434.98 | +1.94% | -0.14% | +8.19% | $19.21M | 13.9× |
Elevance Health, Inc. ELV · US | Healthcare Plans | $85.465B | 1.1% | $393.18 | +1.75% | -0.73% | -3.12% | $8.59M | 16.3× |
Moderna Inc. MRNA · US | Biotechnology | $81.653B | 1.1% | $204.65 | +7.70% | +2.90% | +35.70% | $98.62M | -25.9× |
Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $76.539B | 1% | $728.82 | -0.87% | -7.52% | -14.46% | $24.95M | 17.3× |
The Cigna Group CI · US | Healthcare Plans | $71.734B | 0.9% | $272.10 | +0.58% | +0.03% | -3.80% | $12.49M | 11.2× |
Boston Scientific Corp. BSX · US | Medical Devices | $61.622B | 0.8% | $42.60 | -0.01% | -3.01% | -11.93% | $24.58M | 16.8× |
Natera, Inc. NTRA · US | Diagnostics & Research | $60.374B | 0.8% | $420.40 | +2.45% | +1.90% | +29.29% | $52.55M | -313.9× |